Characteristics of the participants. by Kazuhiro Suzuki (160528)

Subjects:

Comparison of GHQ-12 total scores pre- and post- guideline change in the mask-wearing behavior. by Kazuhiro Suzuki (160528)

Subjects:

Analysis sample data. by Kazuhiro Suzuki (160528)

Subjects:

Multiple linear regression analysis for psychological distress (GHQ-12 scores). by Kazuhiro Suzuki (160528)

Subjects:

R code for data analysis. by Mi Zhou (9884)

“…Negative binomial regression shows that students have the lowest PA in their transition year grade 6, and their screen time decreased with the grade increased. Significant differences can be found across gender. …”

Description of demographics and PA results. by Mi Zhou (9884)

“…Negative binomial regression shows that students have the lowest PA in their transition year grade 6, and their screen time decreased with the grade increased. Significant differences can be found across gender. …”

Trends in adolescent fertility rates in Sierra Leone, 2008–2019. by Augustus Osborne (15249788)

Subjects:

Inequality measures of adolescent fertility rates in Sierra Leone, 2008–2019. by Augustus Osborne (15249788)

Subjects:

Trends in adolescent fertility rates in Sierra Leone by different inequality dimensions, 2008–2019. by Augustus Osborne (15249788)

Subjects:

Subgroup and sensitivity analyses for the primary outcomes. by Jin-Min Gu (17915039)

Subjects:

Forest plot of inflammatory markers. by Jin-Min Gu (17915039)

Subjects:

Flow diagram for the identification of studies included. by Jin-Min Gu (17915039)

Subjects:

Forest plot of the hospital stay length in distinct stages of patients. by Jin-Min Gu (17915039)

Subjects:

Weekly aerobic exercise volume over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Weekly resistance training frequency over time for the DHA and placebo groups combined (n  by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and end of chemotherapy (week 18) in the DHA and placebo groups. by Claire M. Douglas (21238238)

Subjects:

Participant demographic and clinical characteristics. by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 150 minutes/week) or did not meet (< 150 minutes/week) WHO’s aerobic e... by Claire M. Douglas (21238238)

Subjects:

Flow of participants through the DHA WIN RCT. Abbreviations: Docosahexaenoic acid (DHA), Docosahexaenoic acid for Women with Breast Cancer in the Neoadjuvant Setting (DHA WIN), ran... by Claire M. Douglas (21238238)

Subjects:

Quality of life scores at baseline (week 0) and the end of chemotherapy (week 18) in participants that met (≥ 2 times/week) or did not meet (< 2 times/week) WHO’s resistance traini... by Claire M. Douglas (21238238)

Subjects: